Adial Pharmaceuticals (ADIL) Deferred Taxes (2021)
Adial Pharmaceuticals (ADIL) posted Deferred Taxes of -$101031.0 for Q4 2021, down 1552.85% sequentially from $6954.0 in Q1 2021.
Adial Pharmaceuticals (ADIL) Deferred Taxes (2021) Analysis & Trends
Adial Pharmaceuticals has reported Deferred Taxes for 1 years, with the latest figure at -$101031.0 in Q4 2021.
- Quarterly Deferred Taxes changed N/A year-over-year to -$101031.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$94077.0 (changed N/A YoY) and the FY2022 annual result came in at -$502.0, up 99.47% from the prior year.
- Deferred Taxes slipped to -$101031.0 in Q4 2021 per ADIL's latest filing, from $6954.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $6954.0 in Q1 2021 and troughed at -$101031.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Adial Pharmaceuticals | 27.94 Mn | 27.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -101,031.00 |
| Mar 31, 2021 | 6,954.00 |